Cincinnati Sub-Zero’s stability chamber controller is validated to comply with FDA guidance for electronic records and digital signatures.
Cincinnati Sub-Zero’s stability chambers and stability rooms incorporate the EZT-570S controller, which is now validated to comply with the FDA 21 CFR Part 11 guidance document for electronic records and digital signatures. The stability chambers can be used for International Council for Harmonization (ICH) Q1A pharmaceutical stability testing, shelf life testing, package testing, accelerated aging, and other tests.
The touch-screen controller simplifies chamber operation using data logging, ethernet control and monitoring from any smart phone or tablet, alarm notification via email and/or text message, data file backup, full system security, audit trail, digital signatures, and power recovery options.
Source: Cincinnati Sub-Zero
Telix Enters Agreement with ImaginAb to Purchase Next-Gen Therapeutic Candidates
Published: January 13th 2025 | Updated: January 13th 2025The transaction adds a pipeline of early-stage drug candidates against high-value targets to Telix’s portfolio, along with other novel targets currently in the discovery stage.